Altitude Crest Partners Inc. Roivant Sciences Ltd. Transaction History
Altitude Crest Partners Inc.
- $234 Billion
- Q1 2024
A detailed history of Altitude Crest Partners Inc. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Altitude Crest Partners Inc. holds 454,766 shares of ROIV stock, worth $4.81 Million. This represents 2.05% of its overall portfolio holdings.
Number of Shares
454,766
Previous 808,061
43.72%
Holding current value
$4.81 Million
Previous $9.07 Billion
47.18%
% of portfolio
2.05%
Previous 6.07%
Shares
2 transactions
Others Institutions Holding ROIV
# of Institutions
263Shares Held
489MCall Options Held
565KPut Options Held
1.68M-
Sb Investment Advisers (Uk) LTD London, X073MShares$772 Million7.6% of portfolio
-
Viking Global Investors LP69.4MShares$733 Million2.78% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$705 Million65.04% of portfolio
-
Black Rock Inc. New York, NY36.2MShares$383 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.6MShares$377 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.45B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...